{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:14:40Z","timestamp":1761894880404},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.jbspin.2008.11.005","type":"journal-article","created":{"date-parts":[[2009,4,7]],"date-time":"2009-04-07T10:19:02Z","timestamp":1239099542000},"page":"308-311","source":"Crossref","is-referenced-by-count":30,"title":["Spondyloarthropathy and chronic B hepatitis. Effect of anti-TNF therapy"],"prefix":"10.1016","volume":"76","author":[{"given":"Daniel","family":"Wendling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Di Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment","family":"Prati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Toussirot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Herbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2008.11.005_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jbspin.2006.11.020","article-title":"TNFalpha antagonist therapy in patients with joint disease and chronic viral infection","volume":"74","author":"Wendling","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2008.11.005_bib2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/ard.2004.031187","article-title":"Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy","volume":"64","author":"Wendling","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2008.11.005_bib3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2007.10.011","article-title":"Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection","volume":"38","author":"Carroll","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2008.11.005_bib4","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/rheumatology\/kel123","article-title":"Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis","volume":"45","author":"Roux","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2008.11.005_bib5","first-page":"107","article-title":"Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C","volume":"31","author":"Oniankitan","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2008.11.005_bib6","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s10067-006-0392-1","article-title":"Long-term anti-TNFalpha therapy for ankylosing spondylitis in two patients with chronic HBV infection","volume":"26","author":"Sakellariou","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2008.11.005_bib7","first-page":"421","article-title":"Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis","volume":"35","author":"Cansu","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2008.11.005_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.5694\/j.1326-5377.2007.tb01396.x","article-title":"Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis","volume":"187","author":"Ozorio","year":"2007","journal-title":"Med J Aust"},{"key":"10.1016\/j.jbspin.2008.11.005_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10067-006-0253-y","article-title":"Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab","volume":"26","author":"Garc\u00eda Aparicio","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2008.11.005_bib10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jbspin.2007.12.009","article-title":"Infliximab-induced hepatitis: absence of cross-toxicity with etanercept","volume":"15","author":"Thi\u00e9fin","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2008.11.005_bib11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/ard.2005.043257","article-title":"Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies","volume":"65","author":"Calabrese","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2008.11.005_bib12","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1440-1746.2006.04559.x","article-title":"Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approach","volume":"21","author":"Nathan","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl. 1","key":"10.1016\/j.jbspin.2008.11.005_bib13","first-page":"S1","article-title":"Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie, SFR)","volume":"72","author":"Pham","year":"2005","journal-title":"Joint Bone Spine"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X09000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X09000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T10:16:14Z","timestamp":1589710574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X09000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S1297319X09000104"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2008.11.005","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}